U.S. Capital Wealth Advisors’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1M Buy
361,772
+152,065
+73% +$6.56M 0.38% 57
2025
Q4
$8.41M Buy
209,707
+116,151
+124% +$4.6M 0.22% 113
2025
Q3
$3.69M Buy
93,556
+30,896
+49% +$1.14M 0.1% 216
2025
Q2
$2.33M Buy
62,660
+39,339
+169% +$1.33M 0.07% 272
2025
Q1
$781K Buy
+23,321
New +$824K 0.02% 477

Other funds holding CPAI

U.S. Capital Wealth Advisors's CPAI Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 73% in Q1 2026, buying an estimated $6.56M and bringing the position to 361,772 shares worth $15.1M. The position accounts for 0.38% of the portfolio, ranked #57.

U.S. Capital Wealth Advisors first reported a position in CPAI in Q1 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold CPAI as of Q1 2026.

  • U.S. Capital Wealth Advisors held 361,772 shares of Counterpoint Quantitative Equity ETF worth $15.1M as of Q1 2026.
  • U.S. Capital Wealth Advisors bought 152,065 Counterpoint Quantitative Equity ETF shares in Q1 2026, an estimated $6.56M.
  • Counterpoint Quantitative Equity ETF made up 0.38% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #57 holding.
  • U.S. Capital Wealth Advisors first reported a position in Counterpoint Quantitative Equity ETF in Q1 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.